Dariusz Cież

Dr. Dariusz Cież

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
APAleksandra Pałasz
Aleksandra Pałasz
DCDariusz Cież
Dariusz Cież

5 June 2019 in Topics in Current Chemistry
Verified
Journal Article
Open access
PDF file
APAleksandra Pałasz
Aleksandra Pałasz
DCDariusz Cież
Dariusz Cież
BTBartosz Trzewik
Bartosz Trzewik
KJKatarzyna Jędrzejowska
Katarzyna Jędrzejowska
GTGrzegorz Tynor
Grzegorz Tynor
BBBartłomiej Bazan
Bartłomiej Bazan
This review is an effort to summarize recent developments in synthesis of O-glycosides and N-, C-glycosyl molecules with promising antidiabetic potential. Articles published after 2000 are included. First, the O-glycosides used in the treatment of diabetes are presented, followed by the N-glycosides and finally the C-glycosides constituting the largest group of antidiabetic drugs are described. Within each group of glycosides, we presented how the structure of compounds representing potential drugs changes and when discussing chemical compounds of a similar structure, achievements are presented in the chronological order. C-Glycosyl compounds mimicking O-glycosides structure, exhibit the best features in terms of pharmacodynamics and pharmacokinetics. Therefore, the largest part of the article is concerned with the description of the synthesis and biological studies of various C-glycosides. Also N-glycosides such as N-(β-d-glucopyranosyl)-amides, N-(β-d-glucopyranosyl)-ureas, and 1,2,3-triazolyl derivatives belong to the most potent classes of antidiabetic agents. In order to indicate which of the compounds presented in the given sections have the best inhibitory properties, a list of the best inhibitors is presented at the end of each section. In summary, the best inhibitors were selected from each of the summarizing figures and the results of the ranking were placed. In this way, the reader can learn about the structure of the compounds having the best antidiabetic activity. The compounds, whose synthesis was described in the article but did not appear on the figures presenting the structures of the most active inhibitors, did not show proper activity as inhibitors. Thus, the article also presents studies that have not yielded the desired results and show directions of research that should not be followed. In order to show the directions of the latest research, articles from 2018 to 2019 are described in a separate Sect. 5. In Sect. 6, biological mechanisms of action of the glycosides and patents of marketed drugs are described.


24 February 2016 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
DCDariusz Cież
Dariusz Cież
APAleksandra Pałasz
Aleksandra Pałasz
BTBartosz Trzewik
Bartosz Trzewik


22 August 2008 in Synthesis
Verified
Journal Article
Closed access
PDF file
BTBartosz Trzewik
Bartosz Trzewik
DCDariusz Cież
Dariusz Cież
MHMaciej Hodorowicz
Maciej Hodorowicz
KSKatarzyna Stadnicka
Katarzyna Stadnicka
New, stable α-amido-α-aminonitrones were obtained in good yields from 3-oxobutyric acid N-pyridin-2-ylamides and nitrosobenzene. The α-amido-α-aminonitrones were then used as new, versatile building blocks to obtaining various heterocycles with both bielectrophilic and binucleophilic reagents. With diiodomethane as reagent, 1,2,5-oxadiazine derivatives were formed, whereas reactions with aromatic 1,2-, 1,3- and 1,4-diamines yielded quinoxaline, quinazoline, perimidine, and dibenzo[d,f][1,3]diazepine derivatives, respectively.